AgingResearch.NewsJoin free

Anti-platelet glycoprotein autoantibodies

Biomarker

1 paper1 finding

  • Humans1

Associations

1

Severe COVID-19

upin humans1

1 study

  1. Anti-platelet glycoprotein autoantibodies raise the risk of severe COVID-19 in humans.

    “anti-cardiolipin and anti-platelet glycoprotein autoantibodies significantly increased the likelihood of developing a severe COVID-19 phenotype with aging”

    Humanswith aging

    Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach

    npj agingAug 24, 2023

More on Severe COVID-19

Latest

Related